Vanda Pharmaceuticals, Inc. (VNDA)
7.57
+0.34
(+4.70%)
USD |
NASDAQ |
Feb 06, 16:00
7.58
+0.01
(+0.13%)
After-Hours: 20:00
Vanda Pharmaceuticals SG&A Expense (TTM) : 214.26M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| AbbVie, Inc. | 14.01B |
| Axsome Therapeutics, Inc. | 514.57M |
| AnaptysBio, Inc. | 45.14M |
| SELLAS Life Sciences Group, Inc. | 11.21M |